Clinical trial
The Contribution of Endothelin to Vasoreactivity in Atherosclerotic Coronary Arteries
NCT00115583 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Contribution of Endothelin to Vasoreactivity in Atherosclerotic Coronary Arteries
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 1998
- Completion date
- April 30, 2007
- Enrollment
- 200
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, coronary